跳至主要内容
临床试验/NCT06845098
NCT06845098尚未招募不适用

Impact of Thyroid Treatment on Ovarian Function and Pregnancy Outcomes in Women with Differentiated Thyroid Cancer: a Prospective Cohort Study

Zhejiang Provincial People's Hospital1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2025年2月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
300
试验地点
1
主要终点
AMH level

研究概览

简要总结

This project aims to study the effects of different types of thyroid surgery and RAIT on ovarian function and pregnancy outcomes of DTC women of childbearing age, analyze possible risk factors, and assess whether potential risk factors such as age, thyroid stimulating hormone (TSH) levels and positive thyroid antibodies are related to ovarian hypofunction and adverse pregnancy outcomes.

详细描述

  1. Screen the patients in the group according to the inclusion and exclusion criteria and sign the informed consent form (a total of 300 patients were included). Fill in the questionnaire after joining the group. 2) Physical examination of patients before treatment (measure height, weight, waist circumference, hip circumference, body fat distribution and percentage); thyroid function test (thyroid B-ultrasound, TSH, FT3, FT4, TPO-Ab, TG-Ab); baseline ovarian function test (AMH, menstruation 1-3 days Six hormones, observe the ovarian condition and the number of sinus follicles through vaginal B-ultrasound); leave blood for scientific research: 2 tubes of coagulation (serum), 1 tube of whole blood, -80℃ freeze. 3) Different types of thyroid surgery (thyroid unilateral lobe + isthmus resection, total thyroidectomy, total thyroidectomy + RAIT) are treated. 4) 3, 6, 12 and 24 months after treatment, the patients in the group should be followed up on ovarian and thyroid function, including physical examination (measurement of height, weight, waist circumference, hip circumference, body fat distribution and percentage); thyroid function testing (thyroid B-ultrasound, TSH, FT3, FT4, TPO-Ab, T G-Ab); ovarian function test (AMH, six items of sex hormones for 1-3 days of menstruation, observation of ovarian conditions and the number of sinus follicles through vaginal B-ultrasound); retention of blood for scientific research: 2 tubes (serum) of blood-promoting blood, 1 tube of whole blood, -80℃ freezing; record adverse reactions and combined medication. 5) If the patient in the group is pregnant during the follow-up period, the pregnancy follow-up shall be carried out according to the CRF table items at 2, 4, 12, 28 and 37 weeks of pregnancy respectively; delivery follow-up shall be carried out on the day of delivery and 6 weeks after delivery. 6) After the research, collect and sort out data for statistical analysis, summarize and sort out the results and publish them in professional journals in relevant fields in the form of papers.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Age 20-45 years old;
  • •Premenopausal women whose thyroid B-ultrasound + surgical pathology is clearly differentiated thyroid cancer (papillar thyroid cancer or follicular thyroid cancer);
  • •TNM stage is in stage I (T1-3, N0 or N1, M0);
  • •Treatment of thyroid tumor resection: unilateral lobe of the thyroid + isthmus resection, total thyroidectomy, total thyroidectomy + RAIT.

排除标准

  • •Patients with malignant tumors in other parts or low undifferentiated thyroid cancer;
  • •Patients with abnormal liver and kidney function;
  • •TNM stage II and above;
  • •History of ovarian surgery, hysterectomy, pelvic surgery or radiation therapy;
  • •Have the following uterine abnormalities, such as uterine malformation (single-horned uterus, double uterus); untreated mediastinal uterus, submucosal uterine fibroids, multiple endometrial polyps, or severe uterine adhesion.
  • •Patients diagnosed with polycystic ovary syndrome by the Rotterdam standard;
  • •Patients with ovarian failure;
  • •Patients have infectious factors, immune diseases and metabolic diseases that may affect pregnancy outcomes;
  • •Pregnancy contraindications or diseases that have a clear impact on pregnancy.

研究组 & 干预措施

Thyroid one-sided lobe + isthmus resection

Experimental

Thyroid one-sided lobe + isthmus resection

干预措施: Thyroid one-sided lobe + isthmus resection (Procedure)

Total thyroidectomy

Experimental

Total thyroidectomy

干预措施: Total thyroidectomy (Procedure)

Total thyroidectomy + RAIT

Experimental

Total thyroidectomy + RAIT

干预措施: Total thyroidectomy + RAIT (Procedure)

结局指标

主要结局

AMH level

时间窗: before treatment and 3, 6, 12 and 24 months after treatment

Measure the concentration of AMH in serum

次要结局

  • Thyroid function(before tratment and 3, 6, 12 and 24 months after treatment)
  • clinical pregnancy rate(up to 24 months after the treatment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验